Plain-English translation of NCT02814942 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This trial is studying how well cardiac resynchronization therapy (CRT) works in Asian patients with severe heart failure. CRT is a specialized pacemaker-like device that helps the heart pump more effectively by coordinating its contractions. Researchers will collect detailed information about your heart health before and after the device is implanted to understand how it works for Asian patients specifically.
Most heart failure research has focused on European and North American patients, leaving a gap in understanding how this treatment works for Asian populations. This trial aims to fill that gap and provide better information for Asian patients considering this device.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive the heart resynchronization device as part of your normal medical care. Before implantation and at 6 months and 12 months after, you will have heart imaging tests, heart tracings (ECGs), blood work, and a walking test to measure your exercise capacity. The researchers will track how your heart function changes over this year to see how well the device works for you.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Singapore
Enrollment target
~500 participants
Started
January 2011
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2021.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.